Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05544799
Other study ID # K-NDE
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 3, 2021
Est. completion date December 31, 2029

Study information

Verified date October 2023
Source Seoul National University Hospital
Contact Dong-Yeop Shin, MD, PhD
Phone +82220727209
Email stephano.dyshin@gmail.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

An prospective observational study to interview patients who had near death experiences among those who had received intensive care unit intervention during admission in hematology ward.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 31, 2029
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: - Adult patients (=19yrs) who are in admission in the Hematology ward of Seoul National University Hospital, and one of the following conditions. 1. recovered after cardiopulomary resuscitation 2. recovered after mechanical ventilator 3. recovered after ICU care 4. recovered after emergent operation 5. recovered after Shock, coma, altered mentality 6. Other medical conditions approaching death Exclusion Criteria: 1. Those who do not agree to participate this study 2. Those who can not be interviewed due to insufficient recovery from critical medical problems

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
No intervension

Locations

Country Name City State
Korea, Republic of Seoul National University Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of near death experience (NDE) Incidence of case with NDE scale =7 point 5 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02854930 - Near Death Experience (NDE) and Migraine N/A